ESNT Stock Analysis: Buy, Sell, or Hold?

ESNT - Essent Group LTD

SURETY INSURANCE
$62.92
-0.58 (-0.91%) ▼
BUY
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Feb 13, 2026 12d

Get Alerted When ESNT Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
💡 BUY OPPORTUNITY: ESNT shows positive signals but monitor for confirmation. Market pricing in 0.1% annual growth which appears achievable. Moderate conviction.

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$77.27
Based on 4.1% avg growth
INTRINSIC VALUE TODAY
$47.98
Trading above fair value

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 8.6x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: ESNT is currently trading at $62.92, which is considered fair relative to its 30-day fair value range of $61.22 to $65.20. The stock's valuation (Forward PE: 8.7) is in line with its historical norms (8.6). At these levels, the market is pricing in 0.1% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.

Technical Outlook: Technically, ESNT is showing sideways momentum. The price is approaching resistance at $63.50. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.

Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.

Quick Decision Summary

Current Position FAIR
Fair Price Range $61.22 - $65.20
Company Quality Score 65/100 (BUY)
Options IV Signal 41th percentile (NORMAL)
Volume Confirmation HIGH
Confidence Score 68.8%

All Signals

  • NEUTRAL: Price in fair range
  • NEUTRAL: Options fairly priced (IV 41th percentile)
  • NEUTRAL: Mixed technical signals (45/100)
  • BULLISH: High volume confirmation
  • NEUTRAL: Near Wall St target ($68.62)
  • NEUTRAL: Market pricing in 0.1% annual earnings growth - fairly valued

Fair Price Analysis

30-Day Fair Range $61.22 - $65.20
Current vs Fair Value FAIR
Expected Move (7 Days) ±$4.41 (7.0%)

Support & Resistance Levels

Support Level $60.29
Resistance Level $63.50
Current Trend Sideways

Fundamental Context

Forward P/E (Next Year Est.) 8.66
Wall Street Target $68.63 (+8.1%)
Revenue Growth (YoY) -1.5%
Earnings Growth (YoY) 1.2%
Profit Margin 55.6%
Valuation Premium vs History +0.1% premium
PE vs Historical 8.7 vs 8.6 FAIR
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): +0.1% (market-implied from PE analysis)
1-Year Target $63.56 (+0%)
2-Year Target $63.63 (+0%)
3-Year Target $63.69 (+0%)
3-Yr Target (if PE normalizes) (PE: 9→9) PE COMPRESSION $63.25 (0%)
Earnings growth offset by PE compression
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 22.3, Growth: 4.3%) $185.61 (+192%)
Base: (SPY PE: 8.7, Growth: 4.3%) $72.09 (+14%)
Bear: (PE: 7.4, Growth: 4.3%) $61.27 (-4%)
📈 Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (9x PE), but valuation improves significantly next year (9x PE) as earnings recover.
Trailing PE: 9.03 | Current EPS (TTM): $6.88
Bull Case $72.81 (+16%)
Analyst growth 6.6%, PE expands to 9.9
Base Case $66.19 (+5%)
Market implied 6.6%, PE stable at 9.0
Bear Case $42.23 (-33%)
Severe decline -20.0%, PE contracts to 7.7
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Last updated: January 31, 2026 1:02 AM ET
Data refreshes hourly during market hours. Next update: 2:02 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
5
Sells
Net
INSIDERS SELLING
Recent Transactions
Mary Lourdes Gibbons SELL 4000 shares 2025-09-18
Vijay Bhasin SELL 11479 shares 2025-09-18
David B Weinstock SELL 2500 shares 2025-09-15

Top Rated Insurance - Specialty Stocks

Top-rated stocks in Insurance - Specialty by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
RYAN
Ryan Specialty Group Hol…
BUY
13 analysts
$64 45 HOLD
AXS
AXIS Capital Holdings Ltd
BUY
9 analysts
$121 59 HOLD
NMIH
NMI Holdings Inc
STRONG BUY
7 analysts
$45 54 HOLD
RDN
Radian Group Inc
BUY
6 analysts
$39 55 HOLD
ACT
Enact Holdings Inc
SELL
5 analysts
$42 63 BUY

Advanced ESNT Option Strategies

Professional options setups generated by AI based on today's ESNT price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for ESNT

ESNT Technical Chart ESNT Price Prediction ESNT Earnings Date ESNT Investment Advisor ESNT Fair Price Analyzer ESNT Options Advisor ESNT Options Chain ESNT Options Analysis ESNT Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals